Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors (original) (raw)

• Bataille R, Harousseau JL . Multiple myeloma. N Engl J Med 1997; 336: 1657–1664.
  Article CAS PubMed Google Scholar
• Blade J, Kyle RA, Greipp PR . Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40. Br J Haematol 1996; 93: 345–351.
  Article CAS PubMed Google Scholar
• Iwasaki A, Medzhitov R . Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5: 987–995.
  Article CAS PubMed Google Scholar
• Pulendran B . Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol Rev 2004; 199: 227–250.
  Article CAS PubMed Google Scholar
• Manukyan M, Triantafilou K, Triantafilou M, Mackie A, Nilsen N, Espevik T et al. Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1. Eur J Immunol 2005; 35: 911–921.
  Article CAS PubMed Google Scholar
• Alexopoulou L, Holt AC, Medzhitov R, Flavell RA . Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413: 732–738.
  Article CAS PubMed Google Scholar
• Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085–2088.
  Article CAS PubMed Google Scholar
• Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410: 1099–1103.
  Article CAS PubMed Google Scholar
• Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004; 303: 1526–1529.
  Article CAS PubMed Google Scholar
• Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C . Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303: 1529–1531.
  Article CAS PubMed Google Scholar
• Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740–745.
  Article CAS PubMed Google Scholar
• Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001; 194: 863–869.
  Article CAS PubMed PubMed Central Google Scholar
• Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A . Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 2001; 31: 3388–3393.
  Article CAS PubMed Google Scholar
• Lore K, Betts MR, Brenchley JM, Kuruppu J, Khojasteh S, Perfetto S et al. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus and HIV-1-specific T cell responses. J Immunol 2003; 171: 4320–4328.
  Article CAS PubMed Google Scholar
• Kamath AT, Sheasby CE, Tough DF . Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma. J Immunol 2005; 174: 767–776.
  Article CAS PubMed Google Scholar
• Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T et al. Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168: 4531–4537.
  Article CAS PubMed Google Scholar
• Bourke E, Bosisio D, Golay J, Polentarutti N, Mantovani A . The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 2003; 102: 956–963.
  Article PubMed Google Scholar
• Poeck H, Wagner M, Battiany J, Rothenfusser S, Wellisch D, Hornung V et al. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 2004; 103: 3058–3064.
  Article CAS PubMed Google Scholar
• Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J . Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003; 19: 225–234.
  Article CAS PubMed Google Scholar
• Bernasconi NL, Onai N, Lanzavecchia A . A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003; 101: 4500–4504.
  Article CAS PubMed Google Scholar
• Jego G, Robillard N, Puthier D, Amiot M, Accard F, Pineau D et al. Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. Blood 1999; 94: 701–712.
  CAS PubMed Google Scholar
• Heil F, Ahmad-Nejad P, Hemmi H, Hochrein H, Ampenberger F, Gellert T et al. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur J Immunol 2003; 33: 2987–2997.
  Article CAS PubMed Google Scholar
• Hartmann G, Krieg AM . Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 2000; 164: 944–953.
  Article CAS PubMed Google Scholar
• Wetzler LM . The role of Toll-like receptor 2 in microbial disease and immunity. Vaccine 2003; 21 (Suppl 2): S55–S60.
  Article PubMed Google Scholar
• Otsuki T, Hata H, Harada N, Matsuzaki H, Yata K, Wada H et al. Cellular biological differences between human myeloma cell lines KMS-12-PE and KMS-12-BM established from a single patient. Int J Hematol 2000; 72: 216–222.
  CAS PubMed Google Scholar
• Bekeredjian-Ding IB, Wagner M, Hornung V, Giese T, Schnurr M, Endres S et al. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J Immunol 2005; 174: 4043–4050.
  Article PubMed Google Scholar
• Jego G, Pascual V, Palucka AK, Banchereau J . Dendritic cells control B cell growth and differentiation. Curr Dir Autoimmun 2005; 8: 124–139.
  Article CAS PubMed Google Scholar
• Pellat-Deceunynck C, Jego G, Robillard N, Accard F, Amiot M, Bataille R . Reactive plasmacytoses, a model for studying the biology of human plasma cell progenitors and precursors. Hematol J 2000; 1: 362–366.
  Article CAS PubMed Google Scholar
• Davila E, Celis E . Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity. J Immunol 2000; 165: 539–547.
  Article CAS PubMed Google Scholar
• Hafner M, Zawatzky R, Hirtreiter C, Buurman WA, Echtenacher B, Hehlgans T et al. Antimetastatic effect of CpG DNA mediated by type I IFN. Cancer Res 2001; 61: 5523–5528.
  CAS PubMed Google Scholar
• Weigel BJ, Rodeberg DA, Krieg AM, Blazar BR . CpG oligodeoxynucleotides potentiate the antitumor effects of chemotherapy or tumor resection in an orthotopic murine model of rhabdomyosarcoma. Clin Cancer Res 2003; 9: 3105–3114.
  CAS PubMed Google Scholar
• Vicari AP, Chiodoni C, Vaure C, Ait-Yahia S, Dercamp C, Matsos F et al. Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody. J Exp Med 2002; 196: 541–549.
  Article CAS PubMed PubMed Central Google Scholar
• Jahrsdorfer B, Muhlenhoff L, Blackwell SE, Wagner M, Poeck H, Hartmann E et al. B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides. Clin Cancer Res 2005; 11: 1490–1499.
  Article CAS PubMed Google Scholar
• Huang B, Zhao J, Li H, He KL, Chen Y, Mayer L et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 2005; 65: 5009–5014.
  Article CAS PubMed Google Scholar